Clinical Trials Directory

Trials / Terminated

TerminatedNCT06207500

Evaluation of Pharmacist-led Medication Reconciliation Service Benefits in Hospitalised Medical Patients

Impact of Routine Pharmacist-led Medication Reconciliation on Medication Discrepancies and Post-hospital Healthcare Utilisation

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
553 (actual)
Sponsor
The University Clinic of Pulmonary and Allergic Diseases Golnik · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Background: Transitions of care often lead to medication errors and unnecessary healthcare utilisation. It has been repeatedly shown that medication reconciliation can at least partially reduce this risk. Objective: The aim of this prospective pragmatic trial was to evaluate the effectiveness of pharmacist-led medication reconciliation offered to medical patients as part of routine clinical practise. The main questions to be answered were: * the effectiveness of pharmacist-led medication reconciliation on medication discrepancies at discharge and 30 days after discharge * the effectiveness of pharmacist-led medication reconciliation on healthcare utilisation within 30 days after discharge. Participants in the intervention group were offered the following: * medication reconciliation on admission * medication reconciliation on discharge, coupled with patient counselling, provided by clinical pharmacists. Participants in the control group were offered standard care.

Detailed description

Design: pragmatic, prospective, controlled clinical trial Setting: Five general medical wards at the University Clinic of Respiratory and Allergic Diseases in Slovenia: * one intervention ward with a routine pharmacist-led medication reconciliation service * four control wards Data collection: * Data collection and outcome assessment were performed by research pharmacists who were clinical pharmacists or final year clinical pharmacy residents not involved in the treatment of the included patients. * Data for the assessment of medication errors at discharge were obtained from the patients' medical records and the study documentation. * The reason for the patient's hospitalisation was obtained from the discharge letter and divided into acute or planned admissions. The main diagnosis was the reason for admission, while all other patient diagnoses listed were used to assess comorbidity. * Patient comorbidity was assessed using the Charlson Comorbidity Index * For patients in the control group the BPMH was collected in the same way as in the intervention group. However, it was only used for study purposes and was not documented in the patients' medical records * Data on healthcare utilisation and medication discrepancies after hospital discharge were collected through patients or caregivers' phone interview.

Conditions

Interventions

TypeNameDescription
PROCEDUREPharmacist-led Medication ReconciliationThe best possible medication history (BPMH) at hospital admission was obtained from medical and pharmacy records and by interviewing the patient or carers. The BPMH - an accurate and complete (or as close as possible) list of medications the patient is currently taking - was documented in the medication information system. At hospital admission the BPMH was compared with the therapy in hospital to identify discrepancies. All discrepancies were discussed with the treating physician, unintentional discrepancies were reconciled. Intentional discrepancies were documented in the medical records. Prior to discharge from hospital, the BPMH and the medications planned in the discharge therapy were compared again to ensure that all unintentional discrepancies were corrected. Intentional discrepancies were explained in the discharge letter. Individual patient counselling on discharge medications and pharmacotherapy changes was conducted and coupled with written instructions in lay language.

Timeline

Start date
2019-09-30
Primary completion
2020-10-18
Completion
2020-12-31
First posted
2024-01-17
Last updated
2024-01-17

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT06207500. Inclusion in this directory is not an endorsement.